SCHEMBL890317

SCHEMBL890317

OCCc1cnc[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1515167 0.89
SCHEMBL8963903 0.87 HRH3 (0.73)
SCHEMBL4687435 0.87 HRH3 (0.66)
SCHEMBL8964986 0.82 HRH3 (0.79)
SCHEMBL8963886 0.82 HRH3 (0.75)
SCHEMBL1268284 0.82
SCHEMBL27699577 0.80
SCHEMBL8963957 0.80 HRH3 (0.80)
Hydrochloric Acid SCHEMBL7090498 0.80
SCHEMBL2475177 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119711031-B Preparation process of composite plastic woven cloth 上海亚都塑料有限公司 2025-06-24 CN claimed
CN-119711031-A Preparation process of composite plastic woven cloth 上海亚都塑料有限公司 2025-03-28 CN claimed
CN-1298305-A Interleukin-6 production inhibitors TORAY INDUSTRIES (JP) 2001-06-06 CN claimed
US-20260138990-A1 TRICYCLIC FUSED IMIDAZOLE COMPOUNDS AS CD38 MODULATORS AND USES THEREOF AEOVIAN PHARMACEUTICALS INC (US) 2026-05-21 US disclosed
EP-4702026-A1 TRICYCLIC FUSED IMIDAZOLE COMPOUNDS AS CD38 MODULATORS AND USES THEREOF Aeovian Pharmaceuticals, Inc. (US) 2026-03-04 EP disclosed
CN-119711031-B Preparation process of composite plastic woven cloth 上海亚都塑料有限公司 2025-06-24 CN disclosed
CN-119711031-A Preparation process of composite plastic woven cloth 上海亚都塑料有限公司 2025-03-28 CN disclosed
WO-2024226685-A1 TRICYCLIC FUSED IMIDAZOLE COMPOUNDS AS CD38 MODULATORS AND USES THEREOF AEOVIAN PHARMACEUTICALS, INC. (US) 2024-10-31 WO disclosed
US-20230330254-A1 ANTI-GLP1R ANTIBODY-TETHERED DRUG CONJUGATES COMPRISING GLP1 PEPTIDOMIMETICS AND USES THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2023-10-19 US disclosed
US-20230330254-A1 ANTI-GLP1R ANTIBODY-TETHERED DRUG CONJUGATES COMPRISING GLP1 PEPTIDOMIMETICS AND USES THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2023-10-19 US disclosed
CN-116843050-A Method, system, equipment and medium for predicting railway freight traffic 中国铁道科学研究院集团有限公司运输及经济研究所 2023-10-03 CN disclosed
US-20120009260-A1 NANOPARTICLE FILM DELIVERY SYSTEMS AQUESTIVE THERAPEUTICS, INC. 2012-01-12 US disclosed
US-7960394-B2 3,8-dimethyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]-4(3H)-quinazolinone; 6-chloro-3-methyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]pyrido[3,4-d]-pyrimidin-4(3H)-one; 2-[4-(1-cyclopentyl-4-piperidinyloxy)phenyl]-3-methylpyrido[2,3-d]-pyrimidin-4(3H)-one; treats metabolic, nervous system, vascular disorders BANYU PHARMACEUTICAL CO., LTD. (JP) 2011-06-14 US disclosed
US-20100168156-A1 Novel Benzoxathiine Derivative BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-07-01 US disclosed
US-20080275069-A1 Quinazoline Derivative MSD K.K. (JP) 2008-11-06 US disclosed
EP-1944301-A1 NOVEL BENZOXATHIIN DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2008-07-16 EP disclosed
EP-1757594-A1 QUINAZOLINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-02-28 EP disclosed
CN-1217666-C Interleukin-6 production inhibitors TORAY INDUSTRIES (JP) 2005-09-07 CN disclosed
CN-1298305-A Interleukin-6 production inhibitors TORAY INDUSTRIES (JP) 2001-06-06 CN disclosed
EP-0437103-A2 Substituted 5-(alkyl)carboxamide imidazoles SMITHKLINE BEECHAM CORPORATION (US) 1991-07-17 EP disclosed